Kennedy Institute of Rheumatology
A world-leading medical research centre where discovery research drives the development of transformative therapies for chronic inflammatory and degenerative disease.
240 Staff, students and academic visitors
£70M+ in Research Income
GM-CSF drives dysregulated hematopoietic stem cell activity and pathogenic extramedullary myelopoiesis in experimental spondyloarthritis.
Regan-Komito D. et al, (2020), Nat Commun, 11
Singh A. et al, (2019), JCI Insight, 4
Nayar S. et al, (2019), Proc Natl Acad Sci U S A, 116, 13490 - 13497